Patents by Inventor AnnaMarie Daniels

AnnaMarie Daniels has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions of Iboga Alkaloids and Methods of Treatment
    Publication number: 20240100061
    Abstract: Compositions comprising an iboga alkaloid and a cardioprotective agent are provided. Use of the compositions in treating neuropsychiatric disorders are described, where the cardioprotective agent is administered before, during and/or after the iboga alkaloid.
    Type: Application
    Filed: September 14, 2023
    Publication date: March 28, 2024
    Applicants: The Board of Trustees of the Leland Stanford Junior University, Soneira Inc., P.B.C.
    Inventors: Nolan R. Williams, Ian Kratter, AnnaMarie Daniels, Gregory Bird
  • Methods of Treatment With an Iboga Alkaloid
    Publication number: 20240100062
    Abstract: Methods for treating a neuropsychiatric disorder by administering an iboga alkaloid and a cardioprotective agent in conjunction with analysis of brain image data is described. Also described are methods to improve brain health and to slow or reverse brain aging by disorder by administering an iboga alkaloid and a cardioprotective agent, where analysis of brain image data is used to monitor and/or evaluate treatment effectiveness.
    Type: Application
    Filed: September 14, 2023
    Publication date: March 28, 2024
    Applicants: The Board of Trustees of the Leland Stanford Junior University, Soneira Inc., P.B.C.
    Inventors: Nolan R. Williams, John Philip Coetzee, Andrew Dedinas Geoly, AnnaMarie Daniels, Gregory Bird
  • Nasal spray steroid formulation and method
    Publication number: 20060147385
    Abstract: The present invention relates to an improvement in a method of contraception, in treatment of benign gynecological disorders, and in hormone replacement. The improved method includes administering intranasally an estrogenic compound and an androgenic compound, and in some embodiments an optional progestin compound, in a once-daily bolus formulation comprised of the two or three steroids complexed with a cyclodextrin. An intranasal delivery system for administration of the formulation is also described.
    Type: Application
    Filed: March 3, 2006
    Publication date: July 6, 2006
    Inventors: Malcolm Pike, Darcy Spicer, AnnaMarie Daniels, John Daniels
  • Nasal spray steroid formulation and method
    Patent number: 7029657
    Abstract: The present invention relates to an improvement in a method of contraception, in treatment of benign gynecological disorders, and in hormone replacement. The improved method includes administering intranasally an estrogenic compound and an androgenic compound, and in some embodiments an optional progestin compound, in a once-daily bolus formulation comprised of the two or three steroids complexed with a cyclodextrin. An intranasal delivery system for administration of the formulation is also described.
    Type: Grant
    Filed: November 15, 2002
    Date of Patent: April 18, 2006
    Assignee: Balance Pharmaceuticals, Inc.
    Inventors: Malcolm C. Pike, Darcy V. Spicer, AnnaMarie Daniels, John R. Daniels
  • Nasal spray formulation and method
    Publication number: 20060008420
    Abstract: A nasal spray formulation for use in female contraception or in the treatment of benign gynecological disorders is described. The nasal preparation is comprised of a GnRH compound and an estrogenic compound in the form of a water-soluble complex with a water-soluble cyclodextrin. The preparation effectively suppresses ovarian estrogen and progesterone production, and prevents signs and symptoms of estrogen deficiency, without a significant increase in the risk of endometrial hyperplasia.
    Type: Application
    Filed: September 9, 2005
    Publication date: January 12, 2006
    Inventors: John Daniels, Malcolm Pike, Darcy Spicer, AnnaMarie Daniels
  • Nasal spray formulation and method
    Patent number: 6958142
    Abstract: A nasal spray formulation for use in female contraception or in the treatment of benign gynecological disorders is described. The nasal preparation is comprised of a GnRH compound and an estrogenic compound in the form of a water-soluble complex with a water-soluble cyclodextrin. The preparation effectively suppresses ovarian estrogen and progesterone production, and prevents signs and symptoms of estrogen deficiency, without a significant increase in the risk of endometrial hyperplasia.
    Type: Grant
    Filed: November 15, 2002
    Date of Patent: October 25, 2005
    Assignee: Balance Pharmaceuticals, Inc.
    Inventors: John R. Daniels, Malcolm C. Pike, Darcy V. Spicer, AnnaMarie Daniels
  • Nasal spray formulation and method
    Publication number: 20040022739
    Abstract: A nasal spray formulation for use in female contraception or in the treatment of benign gynecological disorders is described. The nasal preparation is comprised of a GnRH compound and an estrogenic compound in the form of a water-soluble complex with a water-soluble cyclodextrin. The preparation effectively suppresses ovarian estrogen and progesterone production, and prevents signs and symptoms of estrogen deficiency, without a significant increase in the risk of endometrial hyperplasia.
    Type: Application
    Filed: November 15, 2002
    Publication date: February 5, 2004
    Inventors: John R. Daniels, Malcolm C. Pike, Darcy V. Spicer, AnnaMarie Daniels
  • Nasal spray steroid formulation and method
    Publication number: 20040022738
    Abstract: The present invention relates to an improvement in a method of contraception, in treatment of benign gynecological disorders, and in hormone replacement. The improved method includes administering intranasally an estrogenic compound and an androgenic compound, and in some embodiments an optional progestin compound, in a once-daily bolus formulation comprised of the two or three steroids complexed with a cyclodextrin. An intranasal delivery system for administration of the formulation is also described.
    Type: Application
    Filed: November 15, 2002
    Publication date: February 5, 2004
    Inventors: Malcolm C. Pike, Darcy V. Spicer, AnnaMarie Daniels, John R. Daniels